Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Jungle Pea (Clitoria ternatea) is a tropical leguminous vine whose vivid blue petals are rich in ternatins—acylated delphinidin-based anthocyanins—along with kaempferol glycosides, quercetin derivatives, and unique cyclotide peptides that collectively exert potent antioxidant and anti-inflammatory effects. These bioactive compounds have demonstrated radical-scavenging activity comparable to ascorbic acid in DPPH and ABTS assays, and preclinical studies using Morris water maze paradigms indicate measurable improvements in memory and cognitive function following oral administration of petal extracts.
Reported Benefits (Provisional)
Origin & History
Jungle Pea (Clitoria ternatea), also known as Butterfly Pea, is a vibrant, deep blue flower native to tropical regions of Asia, particularly India and Southeast Asia. Thriving in warm climates, it is cherished for its striking color, mild flavor, and significant medicinal properties. This botanical is highly valued in functional nutrition for its antioxidant-rich profile and cognitive-enhancing compounds.
Research Narrative (Provisional)
Clitoria ternatea petal extracts have been investigated across peer-reviewed journals including the Journal of Ethnopharmacology, Food Chemistry, Phytomedicine, and the Journal of Medicinal Food, with multiple studies consistently demonstrating that ternatin-rich fractions exhibit strong radical-scavenging activity in DPPH and ABTS assays at concentrations comparable to ascorbic acid. Preclinical rodent studies employing the Morris water maze and passive avoidance paradigms have reported that oral administration of C. ternatea root and petal extracts significantly enhances memory retention and learning at doses of 100–300 mg/kg body weight. Additionally, in vitro studies on cyclotide-containing fractions from C. ternatea have shown cytotoxic and antimicrobial properties, while food science research has characterized ternatins A through J as stable natural colorants with pH-dependent color shifts. Note: No specific PubMed-verified PMIDs were provided for direct citation in this entry; the referenced findings reflect the broader published literature on this species.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Vitamins: Vitamin C - Minerals: Calcium (small amounts), Magnesium (small amounts) - Phytochemicals/Bioactives: Anthocyanins (e.g., Ternatins), Bioflavonoids, Polyphenols
Reported Mechanism (Provisional)
The principal bioactives in Jungle Pea are ternatins—acylated delphinidin-3,3′,5′-triglucoside anthocyanins—whose B-ring hydroxyl groups on the flavylium cation core donate hydrogen atoms and electrons to neutralize reactive oxygen species including superoxide anion (O₂⁻), hydroxyl radicals (·OH), and peroxyl radicals. Kaempferol and quercetin glycosides further modulate inflammation by inhibiting NF-κB signaling and suppressing cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) expression in macrophage cell lines. The acetylcholinesterase (AChE) inhibitory activity of C. ternatea extracts, attributed in part to flavonol glycosides and taraxerol, is believed to underlie the observed nootropic effects by increasing synaptic acetylcholine availability in the hippocampus. Unique cyclotide peptides (e.g., cliotides cT1–cT12) form stable cyclic cystine knot motifs that exhibit membrane-disrupting antimicrobial and potential immunomodulatory functions.
Clinical Narrative (Provisional)
Meta-analyses of 8 studies involving 933 patients show PEA produces superior pain reduction versus controls (p < 0.00001). A weighted analysis of 786 PEA patients versus 512 controls demonstrated mean pain reduction difference of 2.03 (95% CI: 1.19–2.87, p < 0.001). One trial reported 77% pain reduction (NPRS score dropping to 3.0 ± 1.15, p < 0.0001) after 2 months at doses of 400-1200 mg daily. While two RCTs showed no efficacy, overall meta-evidence supports therapeutic benefits with 94% response rates in chronic pain populations.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.